Should diabetes retinal screening intervals change?

Diabetic Medicine

Volumn 30, Issue 1, 2013, Pages 43-45

  Leese, G P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; HIGH RISK PATIENT; HUMAN; INFORMATION TECHNOLOGY; LASER COAGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OPTICAL COHERENCE TOMOGRAPHY; RETINA EXAMINATION; SCREENING TEST; SLIT LAMP; UNITED KINGDOM;

DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EARLY DIAGNOSIS; HUMANS; MASS SCREENING; TIME FACTORS; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84871069395     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03752.x     Document Type: Note

References (16)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30years. Arch Ophthalmol 1984; 102: 520-526.
2. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-532.
3. Kristinsson JK. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis. Acta Ophthalmol Scand Suppl 1997; 223: 1-76.
4. Olafsdóttir E, Stefánsson E. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 2007; 91: 1599-1601.
5. Kohner EM, Stratton IM, Aldington SJ, Holman RR, Mathews DR. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type2 diabetes in the UKPDS (UKPDS52). Diabet Med 2001; 18: 178-184.
6. Agardh E, Tababat-Khani P. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type2 diabetic subjects without retinopathy. Diabetes Care 2011; 34: 1318-1319.
7. Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye 2007; 21: 465-471.
8. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003; 361: 195-200.
9. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in Type1 diabetes in a systematic screening programme. Diabet Med 2003; 20: 758-765.
10. Klein R, Klein BE, Moss SE. The Wisconsin epidemiologic study of diabetic retinopathy: an update. Aust N Z J Ophthalmol 1990; 18: 19-22.
11. Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL et al.Incidence of diabetic retinopathy in people with type2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. Br Med J 2012; 344: e874.
12. Jones CD, Greenwood RH, Misra A, Bachmann MO. Incidence and progression of diabetic retinopathy during 17years of a population-based screening program in England. Diabetes Care 2012; 35: 592-596.
13. White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP et al.Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type1 diabetes mellitus: 10years after the Diabetes Control and Complications Trial. Arch Ophthalmol 2008; 126: 1707-1715.
14. NIHR Health Technology Assessment Programme. Improving the Value of Screening for Diabetic Macular Oedema using Surrogate Photographic Markers (ISMO) Study. Available at http://www.hta.ac.uk/1703 Last accessed 4 July 2012.
15. Yeo ST, Edwards RT, Fargher EA, Luzio SD, Thomas RL, Owens DR. Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experiment. Diabet Med 2012; 29: 869-877.
16. Yeo ST, Edwards RT, Luzio SD, Charles JM, Thomas RL, Owens DR. Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screening. Diabet Med 2012; 29: 878-885.